ResearcherErasmus MCNo recent work listed

Pascal Buijs

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5057804222. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper

Papers 2

Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma. Co-author DOI 10.3390/v7062756 ↗
Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection. Co-author DOI 10.1038/cgt.2013.78 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Bernadette G. van den Hoogen · 2 shared papers, 2014–2015 · strength 0.11
- Paper Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Aden… DOI 10.3390/v7062756 ↗
- Paper Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection. DOI 10.1038/cgt.2013.78 ↗
Casper H.J. van Eijck · 2 shared papers, 2014–2015 · strength 0.11
- Paper Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Aden… DOI 10.3390/v7062756 ↗
- Paper Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection. DOI 10.1038/cgt.2013.78 ↗
Leo J. Hofland · 1 shared paper, 2014 · strength 0.06
- Paper Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection. DOI 10.1038/cgt.2013.78 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.